Back to Journals » OncoTargets and Therapy » Volume 17 » Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
Please verify you are not a robot.
Back to Journals » OncoTargets and Therapy » Volume 17 » Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
Please verify you are not a robot.